These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29858738)

  • 21. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
    Moyle PM
    Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of component structural arrangement on peptide vaccine immunogenicity.
    Alharbi N; Skwarczynski M; Toth I
    Biotechnol Adv; 2022 Nov; 60():108029. PubMed ID: 36028180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An In vivo study: Adjuvant activity of poly-n-vinyl-2-pyrrolidone-co-acrylic acid on immune responses against Melanoma synthetic peptide.
    Kızılbey K; Mansuroğlu B; Derman S; Mustafaeva Akdeste Z
    Bioengineered; 2018 Jan; 9(1):134-143. PubMed ID: 28910565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particle-based platforms for malaria vaccines.
    Wu Y; Narum DL; Fleury S; Jennings G; Yadava A
    Vaccine; 2015 Dec; 33(52):7518-24. PubMed ID: 26458803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing self-assembled peptide nanoparticles in epitope vaccine design.
    Negahdaripour M; Golkar N; Hajighahramani N; Kianpour S; Nezafat N; Ghasemi Y
    Biotechnol Adv; 2017 Sep; 35(5):575-596. PubMed ID: 28522213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.
    Xu Z; Moyle PM
    Bioconjug Chem; 2018 Mar; 29(3):572-586. PubMed ID: 28891637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide Immunotherapy in Vaccine Development: From Epitope to Adjuvant.
    Yang H; Kim DS
    Adv Protein Chem Struct Biol; 2015; 99():1-14. PubMed ID: 26067814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.
    Castro-Díaz N; Salaun B; Perret R; Sierro S; Romero JF; Fernández JA; Rubio-Moraga A; Romero P
    Vaccine; 2012 Jan; 30(2):388-97. PubMed ID: 22079266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particulate vaccines: on the quest for optimal delivery and immune response.
    De Temmerman ML; Rejman J; Demeester J; Irvine DJ; Gander B; De Smedt SC
    Drug Discov Today; 2011 Jul; 16(13-14):569-82. PubMed ID: 21570475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subunit vaccines--antigens, carriers, conjugation methods and the role of adjuvants].
    Jarząb A; Skowicki M; Witkowska D
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1128-43. PubMed ID: 24379254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in vaccine development.
    Moyle PM
    Curr Protoc Microbiol; 2015 Feb; 36():18.1.1-18.1.26. PubMed ID: 25641099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1.
    Kabiri M; Sankian M; Hosseinpour M; Tafaghodi M
    Int J Pharm; 2018 Oct; 549(1-2):404-414. PubMed ID: 30075250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice.
    Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B
    Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in vaccine adjuvants.
    Singh M; O'Hagan DT
    Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small "Non-Natural" Peptides.
    Le HT; Fraleigh NL; Lewicky JD; Boudreau J; Dolinar P; Bhardwaj N; Diaz-Mitoma F; Montaut S; Fallahi S; Martel AL
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.
    Tsoras AN; Champion JA
    Bioconjug Chem; 2018 Mar; 29(3):776-785. PubMed ID: 29436221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-γ as immunoadjuvant in weaning piglets.
    Zhang H; Wen W; Zhao Z; Wang J; Chen H; Qian P; Li X
    Vaccine; 2018 Nov; 36(48):7353-7360. PubMed ID: 30366801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.
    Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A
    Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.
    Friedrich BM; Beasley DWC; Rudra JS
    Vaccine; 2016 Nov; 34(46):5479-5482. PubMed ID: 27670075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.